Campaign Founders
| Dr. David Bramwell CEO, Biosignatures |
 |
| Professor Mark S. Baker Director, Australian Proteome Analysis Facility (APAF@MQ) |
 |
| Dr. Hans Voshol Senior Scientist Protein Sciences, Novartis Institutes for BioMedical Research |
 |
| Dr. Kathryn Lilley Facility Group Leader, Cambridge Centre for Proteomics, University of Cambridge |
 |
| Mike Pisano CEO, NextGen |
 |
| Professor Jan van Oostrum Adjunct Professor, Department of Anatomy and Cell Biology McGill University, Montreal, Canada Head of Business Development, Zeptosens - a Division of Bayer (Schweiz) AG |
  |
| Professor Lennart Martens PRIDE Group Coordinator and Medical Faculty of Ghent University in Belgium |
 |
| Professor Mike Dunn SFI Research Professor of Biomedical Proteomics, Proteome Research Centre, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin |
 |
| Dr. Jules Westbrook Research Fellow, Section of Oncology and Clinical Research, Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James's University Hospital |
 |
| Will Dracup CEO, Nonlinear Dynamics |
 |